Health ❯ Healthcare ❯ Clinical Research

Clinical Trials

Phase 3 Studies Efficacy Studies Phase 3 Trials Randomized Controlled Trials Patient Outcomes Phase 2 Trials Phase III Trials Real-World Evidence Phase II Trials Patient Care

Implanted Cesium-131 Tiles Cut Recurrences and Boost Survival in ROADS Phase III Trial

Intraoperative cesium-131 tiles deliver immediate targeted radiation, reducing cavity recurrences, shortening time to finish cranial care.

FDA Approves Decnupaz for Rare Blood Cancer

Mexico Seeks Role as Latin America Clinical-Trial Hub With New Funding and AI

Autism Leucovorin Prescriptions Jump 2,000% After Media and White House Promotion

Meta-Analysis Backs Low-Dose Digitalis for Heart Failure With Fewer Worsening Events

FDA Approves Auvelity as First Non‑Antipsychotic for Alzheimer’s Agitation

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

Mayo Clinic AI Flags Pancreatic Cancer on CT Scans Up to Three Years Early

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

Tempus AI and USC Launch Collaboration to Integrate AI in Precision Medicine

EMA Panel Recommends Redemplo for Familial Chylomicronaemia Syndrome

EU Drug Panel Backs Sanofi’s Cenrifki for Non‑Relapsing SPMS

VDR Gene Variant Tied to 19% Lower Diabetes Risk With High-Dose Vitamin D3

Anvisa Approves Mounjaro for Type 2 Diabetes in Children Ages 10–17

Opus and Viatris Present Phase 3 Phentolamine Data at ASCRS 2026

FDA Grants Accelerated Approval to Kresladi, First Gene Therapy for Severe Pediatric LAD-1

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

Health Universe Raises $6 Million Led by Kleiner Perkins to Scale Auditable Healthcare AI

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

Apixaban Cuts Bleeding Versus Rivaroxaban in Venous Thrombosis, NEJM Head-to-Head Trial Finds